Jahil et al., in a series of 63 Iraqi CRC patients, found that low CDX2 expression was associated with shorter mean overall survival (17.9 vs. 33.4 months) and correlated with adverse features like older age, mucinous histology, poor differentiation, deeper invasion, nodal involvement and distant metastasis [8]. This evidence concerns the gene CDX2 and colorectal carcinoma.